CLINICAL-EXPERIENCE WITH PEFLOXACIN IN THE THERAPY OF TYPHOID-FEVER

被引：12

作者：

CRISTIANO, P

MORELLI, G

BRIANTE, V

IOVENE, MR

SIMIOLI, F

ALTUCCI, P

机构：

[1] HOSP INFECT DIS D COTUGNO, NAPLES, ITALY

[2] UNIV NAPLES, SCH MED 1, INST INTERNAL MED, I-80138 NAPLES, ITALY

来源：

INFECTION | 1989年 / 17卷 / 02期

关键词：

D O I：

10.1007/BF01646882

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：86 / 87

页数：2

共 15 条

[1]

BAUER AW, 1966, AM J CLIN PATHOL, V45, P493

[2] CHLORAMPHENICOL-RESISTANT TYPHOID-FEVER IN VIETNAM ASSOCIATED WITH-R FACTOR [J].

BUTLER, T ;

ARNOLD, K ;

LINH, NN ;

POLLACK, M .

LANCET, 1973, 2 (7836) :983-985

[3] INVITRO ACTIVITY OF PEFLOXACIN COMPARED TO ENOXACIN, NORFLOXACIN, GENTAMICIN AND NEW BETA-LACTAMS [J].

CLARKE, AM ;

ZEMCOV, SJV ;

CAMPBELL, ME .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (01) :39-44

[4] SALMONELLA-TYPHI INVIVO ACQUIRES RESISTANCE TO BOTH CHLORAMPHENICOL AND CO-TRIMOXAZOLE [J].

DATTA, N ;

RICHARDS, H ;

DATTA, C .

LANCET, 1981, 1 (8231) :1181-1183

[5]

ERICSSON HM, 1971, ACTA PATHOLOG MICROB, P1

[6] PHARMACOKINETIC BEHAVIOR OF PEFLOXACIN IN MAN [J].

FOURTILLAN, JB .

REVUE DE MEDECINE INTERNE, 1986, 7 (02) :185-195

[7]

Hook E.W., 1985, PRINCIPLES PRACTICE, P1256

[8] ABSORPTION, DISTRIBUTION, METABOLIC-FATE, AND ELIMINATION OF PEFLOXACIN MESYLATE IN MICE, RATS, DOGS, MONKEYS, AND HUMANS [J].

MONTAY, G ;

GOUEFFON, Y ;

ROQUET, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :463-472

[9]

MORELLI G, 1985, Giornale di Malattie Infettive e Parassitarie, V37, P823

[10]

PANGON B, 1983, 13TH P INT C CHEM VI

← 1 2 →